AG-825 is a selective, ATP-competitive, tyrosine phosphorylation ErbB2 inhibitor with an IC50 of 0.35 µM. AG825 significantly accelerates Apoptosis of human neutrophils. AG-825 increases beta1AR density. AAG-825 has anticancer and anti-inflammatory activities. AAG-825 can be used in cardiovascular disease research[1][2][3][4][5][6][7].
Molekulargewicht:
397.47
Reinheit:
98.02
CAS Nummer:
[149092-50-2]
Formel:
C19H15N3O3S2
Target-Kategorie:
Adrenergic Receptor,Apoptosis,EGFR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten